UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_____________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of report (Date of earliest event reported): November 19, 2019


STRATA SKIN SCIENCES, INC.
(Exact Name of Registrant Specified in Charter)
 
Delaware
000-51481
13-3986004
(State or Other
(Commission File
(I.R.S. Employer
Jurisdiction of Incorporation)
Number)
Identification No.)

 
5 Walnut Grove Drive, Suite 140, Horsham, Pennsylvania
19044
 
 
(Address of Principal Executive Offices)
(Zip Code)
 

Registrant's telephone number, including area code:   215-619-3200

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

□          Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

□          Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

□          Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

□          Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol(s)
Name of each exchange on which registered
Common Stock, $0.001 par value per share
SSKN
The NASDAQ Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company □

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. □


Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On November 19, 2019, STRATA Skin Sciences, Inc. (the “Company”) received notice from The NASDAQ Stock Market (“Nasdaq”) that, STRATA has regained compliance with the Nasdaq listing requirements as required by Rule 5150(c)(1), the scheduled hearing before the Nasdaq Hearings Panel has been cancelled and the Company will continue to trade on Nasdaq.
 

Item 7.01.          Regulation FD Disclosure.

On November 19, 2019, the Company issued a press release in connection with the notice of potential delisting discussed in Item 3.01.

Item 9.01          Financial Statements and Exhibits

(d) Exhibits

99.1          Press Release dated November 19, 2019 issued by STRATA Skin Sciences, Inc.

SIGNATURE
 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 

 
 
STRATA SKIN SCIENCES, INC.
 
 
 
 
 
Date: November 19, 2019
By:
/s/ Matthew C. Hill           
 
 
 
Matthew C. Hill
 
 
 
Chief Financial Officer
 

 


- 2 -
Strata Skin Sciences (NASDAQ:SSKN)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Strata Skin Sciences Charts.
Strata Skin Sciences (NASDAQ:SSKN)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Strata Skin Sciences Charts.